TGF-β1mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway
- 1 December 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 301 (6) , F1281-F1292
Abstract
The immunosuppressant drugs cyclosporine A (CsA) and sirolimus (SRL) used in combination demonstrated beneficial effects in organ transplantation, but this combination can also result in increased adverse effects. We previously showed that not only CsA treatment but also its combination with SRL decreased paracellular permeability in renal proximal tubular cells by modification of the tight junction proteins, claudins, through ERK1/2 signaling pathway. In this present study, evidence is presented that not only CsA but also the combination of CsA/SRL may have adverse effects on the barrier function of renal proximal cells, at least in part, through the expression of the cytokine transforming growth factor (TGF)-β1. CsA treatment upregulated TGF-β1gene expression and this upregulation was enhanced when CsA and SRL were applied together. Addition of TGF-β1(5 ng/ml) altered the barrier function with increased transepithelial electrical resistance (TER) and claudin-1 expression. Use of a TGF-β1-blocking antibody or blockage of TGF-β1receptor kinase activity with SD208 prevented the CsA- and CsA/SRL-induced increase in TER. No evidence was found in the present studies to indicate that CsA or CsA/SRL treatment activated the TGF-β1Smad canonical signaling pathway, whereas addition of TGF-β1(5 ng/ml) did activate the Smad pathway. Addition of the ERK1/2 signaling inhibitor U0126 was able to prevent the TGF-β1-mediated increase in TER and claudin expression. It is most likely that the CsA- and CsA/SRL-induced increases in TGF-β1expression may not be sufficient to trigger the Smad pathway but however may trigger other TGF-β1receptor-mediated signaling including the ERK1/2 signaling pathway.Keywords
This publication has 35 references indexed in Scilit:
- Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome MiceScience, 2011
- Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expressionAmerican Journal of Physiology-Renal Physiology, 2010
- Protein kinase C beta overexpression induces fibrotic effects in human proximal tubular epithelial cellsThe International Journal of Biochemistry & Cell Biology, 2008
- TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcAThe EMBO Journal, 2007
- Role for TGF-β in Cyclosporine-Induced Modulation of Renal Epithelial Barrier FunctionJournal of the American Society of Nephrology, 2007
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- RAPAMYCIN INDUCES TRANSFORMING GROWTH FACTOR-?? PRODUCTION BY LYMPHOCYTES1Transplantation, 2000
- TRANSFORMING GROWTH FACTOR (TGF)-?? MIMICS AND ANTI-TGF-?? ANTIBODY ABROGATES THE IN VIVO EFFECTS OF CYCLOSPORINETransplantation, 1999
- Antagonistic Regulation of Tight Junction Dynamics by Glucocorticoids and Transforming Growth Factor-βin Mouse Mammary Epithelial CellsJournal of Biological Chemistry, 1996
- QUALITY OF LIFE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1988